Document is current
Any future updates will be listed below
-
Authors
af Geijerstam, Peder https://orcid.org/0000-0001-6038-5131
Joelsson, Annelie
Rådholm, Karin https://orcid.org/0000-0003-3120-0913
Nyström, Fredrik H. https://orcid.org/0000-0002-1680-1000
-
Funding
Funding for this research was provided by:
The Primary Health Care Centers Research Fund, Region Östergötland, Sweden (RÖ 2023/11273)
King Gustaf V and Queen Victoria Freemason Foundation
Linköping University
- License Information
-
More Information
Article History
Received: 18 September 2024
Accepted: 25 March 2025
First Online: 16 April 2025
Declarations
:
: FN has received consulting fees from most pharmaceutical companies in the field of hypertension and diabetes, as well as Haypp group and the Environment and Public Health Institute of Sweden related to his previous trial on the acute effects on nicotine in snus. These organizations had no role in the conception, design, analysis or reporting of this study, and the consulting fees were unrelated to the current project. AJ has received consulting fees from Sanofi and KR has received consulting fees from Astra Zeneca. These organization had no role in the conception, design, analysis or reporting of this study, and the consulting fees were unrelated to the current project. All other authors declare no competing interests.
